EF Hutton Appoints Sean Corcoran, Managing Director, Equity
New York, NY, Feb. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- EF Hutton, division of Benchmark Investments, LLC
Globe Newswire23-02-2023, 02:19
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA 8-10-2024, 18:00